Patents by Inventor Maayan LUFTON

Maayan LUFTON has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11633434
    Abstract: Kits and composition comprising: (i) a thermo-responsive hydrogel characterized by a viscosity suitable for hardening after administration on a subject's skin; (ii) a bacterial growth medium; and optionally, (iii) a population of non-pathogenic viable bacteria, are provided. Methods for topically delivering a therapeutic or cosmeceutical agent such as for inhibiting or reducing growth of microorganisms on a subject's skin are further provided.
    Type: Grant
    Filed: September 6, 2018
    Date of Patent: April 25, 2023
    Assignee: TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED
    Inventors: Boaz Mizrahi, Maayan Lufton
  • Publication number: 20200215124
    Abstract: Kits and composition comprising: (i) a thermo-responsive hydrogel characterized by a viscosity suitable for hardening after administration on a subject's skin; (ii) a bacterial growth medium; and optionally, (iii) a population of non-pathogenic viable bacteria, are provided. Methods for topically delivering a therapeutic or cosmeceutical agent such as for inhibiting or reducing growth of microorganisms on a subject's skin are further provided.
    Type: Application
    Filed: September 6, 2018
    Publication date: July 9, 2020
    Inventors: Boaz MIZRAHI, Maayan LUFTON
  • Patent number: 10240132
    Abstract: Chimeric polypeptides comprising a dihydrotestosterone (DHT) reductase moiety, such as 3 alpha-hydroxysteroid dehydrogenase (3?-HSD), fused to a signal peptide moiety, polynucleotides encoding same, and compositions comprising at least one microorganism cell capable of secreting the chimeric polypeptide, are provided. Further provided are methods and kits for treating, preventing or ameliorating androgen-dependent disorders, including but not limited to androgenic alopecia.
    Type: Grant
    Filed: March 28, 2017
    Date of Patent: March 26, 2019
    Assignee: TECHNION RESEARCH & DEVELOPMENT FOUNDATION LTD.
    Inventors: Roee Amit, Alexey Tomsov, Orna Atar, Liron Abrahami, Yael Annis, Roni Cohen, Alexandra Ereskovsky, Noa Katz, Lior Levy, Maayan Lufton, Tal Ofek, Sagi Sheinkman, Nitzan Shmuel, Inbal Vaknin, Ruth Veksler, Adi Yannai
  • Publication number: 20170275596
    Abstract: Chimeric polypeptides comprising a dihydrotestosterone (DHT) reductase moiety, such as 3 alpha-hydroxysteroid dehydrogenase (3?-HSD), fused to a signal peptide moiety, polynucleotides encoding same, and compositions comprising at least one microorganism cell capable of secreting the chimeric polypeptide, are provided. Further provided are methods and kits for treating, preventing or ameliorating androgen-dependent disorders, including but not limited to androgenic alopecia.
    Type: Application
    Filed: March 28, 2017
    Publication date: September 28, 2017
    Inventors: Roee AMIT, Alexey TOMSOV, Orna ATAR, Liron ABRAHAMI, Yael ANNIS, Roni COHEN, Alexandra ERESKOVSKY, Noa KATZ, Lior LEVY, Maayan LUFTON, Tal OFEK, Sagi SHEINKMAN, Nitzan SHMUEL, Inbal VAKNIN, Ruth VEKSLER, Adi YANNAI